Study: THC/CBD Spray Provides Pain Relief to Multiple Sclerosis Patients

Sativex, a medical spray made from cannabis using equal parts THC and CBD, is effective in providing pain relief to those with multiple sclerosis, according to newly released research.

“Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) (nabiximols or Sativex®) is an oromucosal spray formulation containing THC and CBD at an approximately 1:1 fixed ratio”, states the abstract of the study, which was published by the open access journal Medicines. “Its administration for the treatment of pain in patients with multiple sclerosis (MS) has been established. ”

Noting that “MS patients generally complain of different kinds of pain, including spasticity-related and neuropathic pain”, researchers “compared and evaluated pain modulation and thermal/pain threshold of MS patients before and after THC/CBD administration.” 19 MS patients underwent “clinical examination, numerical rating scale (NRS), quantitative sensory testing (QST), and laser-evoked potentials (LEPs) before and after 1 month of therapy.” Psychophysiological and neurophysiological data were compared to sex- and age-matched controls.

Read moreStudy: THC/CBD Spray Provides Pain Relief to Multiple Sclerosis Patients